Long-acting bronchodilators are used in asthma, so may also benefit people with bronchiectasis. However, there is no good evidence for this at present.
閱讀完整摘要
Symptoms of bronchiectasis include chronic productive cough, wheeze, breathlessness and recurrent infections of the lower respiratory tract. Long-acting bronchodilators are being used more frequently in the management of people with this condition.
目的
To determine the effectiveness of long-acting bronchodilators in the management of bronchiectasis that is not due to cystic fibrosis.
搜尋策略
We searched the Cochrane Airways Group Specialised Register of bronchiectasis trials. The latest searches were carried out in August 2010.
選擇標準
Randomised controlled trials, with or without masking.
資料收集與分析
The results of searches were reviewed against pre-specified criteria.
主要結果
We were unable to identify any randomised controlled trials investigating the effectiveness of long-acting bronchodilator therapy in the management of bronchiectasis. An update search in August 2010 did not identify any new studies.
作者結論
Further research is needed to establish if long-acting bronchodilators have a role in the management of people with bronchiectasis.
